News
Podcasts
Events
Jobs
Companies
Hotbeds
More
Advertise

SUBSCRIBE

SUBSCRIBE

News
Podcasts
Events
Jobs
Companies
Hotbeds
More
Advertise

Search Query

Search Results

Looking for jobs? Search jobs

6,588 Results

Type

Article (299)
Press Release (6289)

Section

Business (1996)
Career Advice (4)
Deals (355)
Drug Development (959)
FDA (118)
Job Trends (107)
News (3388)
Policy (245)

Tag

Date

Last 7 days (4)
Last 30 days (14)
Last 365 days (219)
2026 (17)
2025 (220)
2024 (308)
2023 (444)
2022 (460)
2021 (436)
2020 (485)
2019 (484)
2018 (444)
2017 (384)
2016 (330)
2015 (428)
2014 (288)
2013 (289)
2012 (226)
2011 (190)
2010 (158)

Location

Filters

Type

Article (299)
Press Release (6289)

Section

Business (1996)
Career Advice (4)
Deals (355)
Drug Development (959)
FDA (118)
Job Trends (107)
News (3388)
Policy (245)

Tag

Date

Last 7 days (4)
Last 30 days (14)
Last 365 days (219)
2026 (17)
2025 (220)
2024 (308)
2023 (444)
2022 (460)
2021 (436)
2020 (485)
2019 (484)
2018 (444)
2017 (384)
2016 (330)
2015 (428)
2014 (288)
2013 (289)
2012 (226)
2011 (190)
2010 (158)

Location

6,588 Results for "berg".

Sort By

Business

Memo Therapeutics AG Appoints Erik van den Berg as Chief Executive Officer

Memo Therapeutics AG, a late-stage biotech company developing best-in-class therapeutic antibodies, announced the appointment of Erik van den Berg as Chief Executive Officer.

November 16, 2023
·
3 min read
Pharm Country

Amarin Names Aaron Berg Interim President & Chief Executive Officer and Adds Oliver O’Connor to Company’s Board of Directors

Amarin Corporation plc announced that the Company’s Board of Directors has appointed Aaron Berg, currently Amarin’s Executive Vice President and President of the U.S. Business, as Interim President and Chief Executive Officer.

April 17, 2023
·
5 min read
Business

Vaxart Appoints Edward Berg as Senior Vice President and General Counsel

Vaxart, Inc. announced the appointment of Edward B. Berg as the Company’s first in-house General Counsel.

February 14, 2022
·
6 min read
Genetown

BERG To Present Latest Glioblastoma [GBM] Treatment Data At Society For Neuro-Onocology 2021 Meeting

BERG’s presentations will explore mechanics of BERG’s Interrogative Biology® Platform and application of BPM 31510’s anti-cancer influence on GBM

July 14, 2021
·
4 min read
Pharm Country

Amarin Board of Directors Announces CEO Transition

Amarin Corporation plc today announced that the Company’s Board of Directors has appointed Aaron Berg, currently Amarin’s Executive Vice President and President of the U.S. Business, as President and Chief Executive Officer (CEO).

June 4, 2024
·
5 min read
Genetown

BERG Reveals New Study That Will Seek to Enhance Diagnosis and Treatment of Prostate Cancer

BERG announced the publication of a new study, entitled “Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia” in Scientific Reports.

July 29, 2021
·
3 min read
Genetown

BERG Presents New Research on Potential Therapeutic Path to Fight Huntington’s Disease at The Society for Neuroscience (SfN) Annual Meeting

BERG, the clinical stage biotech that employs patient biology and artificial intelligence (AI) to research diseases and develop innovative treatments, today announced their participation at the Society for Neuroscience (SfN) Annual Meeting from November 8-11, 2021.

November 8, 2021
·
3 min read
Genetown

BERG to Present Latest Research to Improve Pancreatic Treatment at The European Society for Medical Oncology (ESMO) 2021 Congress

BERG, a clinical-stage biotech that employs patient biology and artificial intelligence (AI) to research diseases and develop innovative treatments, today announced its participation at the European Society for Medical Oncology (ESMO) 2021 Congress, from September 16-21, 2021.

September 16, 2021
·
4 min read
Business

CareCentrix Adds Charles G. Berg to Board of Directors

CareCentrix, the leader in tech-enabled post-acute and home-based solutions, has added Charles Berg to its board of directors

July 21, 2020
·
2 min read
Genetown

BERG Files Patent Application For First In Class Small Molecule Modulators Of A Novel Target Identified By BERG’s Interrogative Biology® Platform

Ubiquitin Conjugating Enzyme serves as key target to BERG’s oncology therapeutics discovery efforts

February 27, 2020
·
3 min read

1 of 659

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.

Explore
- News
- Jobs
- Newsletters
- Podcasts
- Webinars
- Hotbeds
- Companies
More
About
Advertise

© 1985 - 2026 BioSpace.com. All rights reserved.

twitter
instagram
facebook
linkedin